Amphastar Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
37.25
|
|
Average Rating
|
3.83
|
|
# Strong Buys
|
2
|
|
# Buys
|
1
|
|
# Holds
|
3
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
0.39
|
0.38
|
-0.01
|
-2.56%
|
|
2022-06-30
|
0.35
|
0.39
|
0.04
|
11.43%
|
|
2022-03-31
|
0.36
|
0.47
|
0.11
|
30.56%
|
|
2021-12-31
|
0.36
|
0.42
|
0.06
|
16.67%
|
|
2021-09-30
|
0.24
|
0.46
|
0.22
|
91.67%
|
|
2021-06-30
|
0.21
|
0.21
|
0.00
|
0.00%
|
|
2021-03-31
|
0.18
|
0.27
|
0.09
|
50.00%
|
|
2020-12-31
|
0.14
|
0.16
|
0.02
|
14.29%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
1.24
|
|
2021-12-31
|
1.36
|
|
2020-12-31
|
0.64
|
|
2019-12-31
|
0.35
|
|
2018-12-31
|
0.23
|
|
2017-12-31
|
0.37
|
|
2016-12-31
|
0.50
|
|
2015-12-31
|
0.08
|
|
2014-12-31
|
-0.13
|